News on Medial

Brain health platform Ivory raises $1 Mn in seed round

EntrackrEntrackr · 1m ago
Brain health platform Ivory raises $1 Mn in seed round
Medial

Brain health platform Ivory has raised $1 million in a seed funding round from Draper Associates, SAGE Venture Fund, MoSJE, IFCI Ventures, and SIDBI. It was also featured on Shark Tank India last year. The Mumbai-based startup had earlier raised $1 million in a funding round co-led by IIM-A Ventures and Capital A in April last year and $500K from Capital A in February 2024. The proceeds will be utilised to strengthen the technology stack, expand clinical capabilities, and enhance product offerings, particularly in building scalable, evidence-based solutions, Ivory said in a press release. Co-founded in early 2023 by Issac John and Rahul Krishnan, Ivory is a brain health startup focused on early detection and proactive cognitive care. By combining neuroscience, neuropsychology, and data-driven interventions, the platform helps individuals maintain and enhance their cognitive well-being. The company offers clinical-grade cognitive assessments and personalised brain health solutions through its app, enabling users to track and optimise their cognitive health. It is supported by a multidisciplinary clinical team spanning neuroscience, neurology, general medicine, and neuropsychology. Ivory is addressing a critical gap in India’s healthcare ecosystem by making cognitive screening accessible, trackable, and a part of routine preventive care. It has also been expanding partnerships across the healthcare ecosystem and recently collaborated with Metropolis Healthcare to launch the TruHealth Mind & Body package—an integrated preventive health offering that combines pathology diagnostics with neuroscience-based cognitive assessments.

Related News

Lifetime Health raises $1.5 Mn in seed round

EntrackrEntrackr · 1y ago
Lifetime Health raises $1.5 Mn in seed round
Medial

Lifetime Health, a digital platform for at-home care, has secured $1.5 million in a seed round led by US-based venture capital firm The Garage Syndicate along with participation from other angel investors. The company had previously raised $900,000 in its last round from an existing investor. The fresh proceeds will be deployed towards further development, Lifetime Health said in a press release. Co-founded in 2023 by Konstantin Riabtsev, Michail Vorobiev and Nabil Ahmed, Lifetime Health is a digital platform for hospital-at-home care providing phlebotomy services, diagnostic tools, medical devices, nursing care, physiotherapy, and postoperative care all in one app. Its automated platform ensures fast, high-quality, and affordable service, from the client’s order to the nurse’s departure and results processing. Lifetime Health is currently operating in Bengaluru and its partner network includes 200 local clinics. It aims to reach major Indian cities and connect over 10,000 medical offices nationwide. intends to enable medical service orders at home for residents across Bangalore and its suburbs, and expand to Mumbai. The platform expects to have 1,000 doctors registered on the platform, with at least 300 of them becoming active users who can schedule appointments online, make appointments and recommendations, and maintain patient histories in digital format. The other startups in this space are Caresathome, CASAMED, Muse Diagnostic, Care24-India, and others.

You Care Lifestyle raises $1 Mn in pre-seed round

EntrackrEntrackr · 1y ago
You Care Lifestyle raises $1 Mn in pre-seed round
Medial

You Care Lifestyle raises $1 Mn in pre-seed round Independent verification platform You Care Lifestyle (YCL) has raised $1 million in a pre-seed funding round co-led by Luke Coutinho and Narendra Firodiya. The proceeds will be used to strengthen the processes for verification and authentication of products, support and invest in emerging clean brands, helping them scale and gain consumer trust, YCL said in a press release. Launched this year, You Care Lifestyle is an independent verification entity in the health and wellness space. The company verifies the safety, purity, and quality of products and services across various categories, including groceries, food, nutraceuticals, beauty and personal care items, pathology labs, and other lifestyle-related offerings. The Mumbai-based startup aims to create a trustworthy third-party verification platform, addresses critical issues like mislabelling and misinformation, and drives a behaviour shift towards informed consumer choice. YCL aims to empower brands to prioritise health-conscious products and to uphold the highest quality standards, and consumers to prioritise health-conscious decisions and inspire them to make choices of authentic products. YCL intends to expand the company’s offerings and plans to onboard brands. The company will look to test and verify approx 90-100 brands across food and cosmetic sectors by the end of 2025. The startup claims that it has signed with 37 products, 24 of which have successfully passed third-party lab tests, and 18 products are now available on the website. These products will feature the distinctive 'Pink Tiger Stamp,' an independent verification mark that signifies both approval and the quality assurance of the ingredients after rigorous testing. YCL aspires to bridge the gap between authenticity and consumer trust by creating a rigorous and reliable third-party verification system. The platform is committed to identifying and investing in businesses that share a vision of transparency, integrity, and consumer well-being.

Visit Health raises $30 Mn in primary and secondary transaction

EntrackrEntrackr · 1y ago
Visit Health raises $30 Mn in primary and secondary transaction
Medial

Telehealth and wellness platform Visit Health has raised Rs 250 crore ($30 million) in a combination of primary and secondary purchase of stake in the company held by Docprime Technologies, the current promoters and employees. Visit Health will use the funds to expand its business which involves a strategic partnership with health and wellness platform TatvaCare, the company said in a press release. In October 2021, DocPrime invested around $7.5 million in Visit Health. The New Delhi-based company had also scooped up $1.4 million in seed round from investors such as MapmyIndia, Snapdeal co-founders Kunal Bahl and Rohit Bansal, and Hetero Drugs Director Murali Krishna. In May, PB Fintech said that it will divest 29% of its holdings in Visit Health, which will be valued at Rs 76 crore ($9 million). The firm also added that it will make a divestment of Rs 2 crore in Visit Internet. Eight-year-old Visit Health offers customized wellness & OPD programs for SMEs and corporates’ employees and their families. It claims to serve more than 400 companies through its network of hospitals. Startup data intelligence platform TheKredible shows that DocPrime controlled 14.4% stake in Visit Health as of Series A round. For the fiscal year ending in March 2023 (FY23), Visit Health registered nearly three-fold jump in its revenue to Rs 53 crore from Rs 17.55 crore in FY22. The company managed to keep its losses below Rs 1 crore in FY23. It is yet to file FY24 numbers. On Tuesday, PB Fintech released its quarterly results. The company’s revenue slipped to Rs 1,010 crore in Q1 FY25 as compared to Rs 1,090 crore during the quarter ended March 2024. Despite the decline in scale, it managed to maintain steady profits, which stood at Rs 60 crore in Q1 FY25. Update: The headline and story have been updated to add correct information from Visit Health’s press release.

Download the medial app to read full posts, comements and news.